Manganese-based magnetic resonance contrast agents
US-2015336996-A1 · Nov 26, 2015 · US
US9463254B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9463254-B2 |
| Application number | US-201414298688-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 6, 2014 |
| Priority date | Jun 7, 2013 |
| Publication date | Oct 11, 2016 |
| Grant date | Oct 11, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
In some aspects, the present invention provides novel ligands, which may be used to make novel dual-modality imaging agents, for example, for PET and MRI imaging. In further aspects, by the present disclosure also provides methods of use and methods of preparation of the novel ligands, metal complexes, and imaging agents thereof.
Opening claim text (preview).
What is claimed: 1. A compound of the formula: wherein: R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are each independently selected from X 1 , X 2 , and X 3 are each independently alkanediyl (C≦12) , alkenediyl (C≦12) , alkynediyl (C≦12) , arenediyl (C≦12) , heteroarenediyl (C≦12) , alkoxydiyl (C≦12) , alkylaminodiyl (C≦12) , or a substituted version of any of these groups; or an amino acid residue, an amino acid residue linked to a targeting moiety, a PEG linker comprising between 2 and 200 repeating units; Y 1 , Y 2 , Y 3 , Y 4 , Y 5 , and Y 6 are each independently alkanediyl (C≦12) , alkenediyl (C≦12) , alkynediyl (C≦12) , arenediyl (C≦12) , heteroarenediyl (C≦12) , alkoxydiyl (C≦12) , alkylaminodiyl (C≦12) , or a substituted version of any of these groups; or an amino acid residue, an amino acid residue linked to a targeting moiety, a PEG linker comprising between 2 and 200 repeating units; and provided that all of R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are not or a metal complex or salt thereof. 2. The compound of claim 1 , wherein the compound is further defined as: or a metal complex or salt thereof.
General or multifunctional contrast agents, e.g. chelated agents · CPC title
conjugates with carriers being macromolecules · CPC title
Peptides, e.g. proteins · CPC title
dendrimers, dendrons, hyperbranched compounds · CPC title
conjugates with carriers being peptides, polyamino acids or proteins (antibodies A61K51/10) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.